As of 2025-04-23, the Relative Valuation of Design Therapeutics Inc (DSGN) is (11.75) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.59 USD, the upside of Design Therapeutics Inc based on Relative Valuation is -427.3%.
The range of the Relative Valuation is (10.92) - (17.33) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.5x - 22.7x | 13.9x |
| Forward P/E multiples | 11.8x - 19.8x | 13.0x |
| Fair Price | (10.92) - (17.33) | (11.75) |
| Upside | -404.2% - -582.8% | -427.3% |
| Date | P/E |
| 2025-04-21 | -4.05 |
| 2025-04-17 | -4.01 |
| 2025-04-16 | -3.87 |
| 2025-04-15 | -3.80 |
| 2025-04-14 | -3.72 |
| 2025-04-11 | -3.31 |
| 2025-04-10 | -3.19 |
| 2025-04-09 | -3.39 |
| 2025-04-08 | -3.38 |
| 2025-04-07 | -3.59 |
| 2025-04-04 | -3.89 |
| 2025-04-03 | -4.03 |
| 2025-04-02 | -4.34 |
| 2025-04-01 | -4.13 |
| 2025-03-31 | -4.42 |
| 2025-03-28 | -4.82 |
| 2025-03-27 | -4.80 |
| 2025-03-26 | -4.75 |
| 2025-03-25 | -5.25 |
| 2025-03-24 | -5.64 |
| 2025-03-21 | -5.32 |
| 2025-03-20 | -5.31 |
| 2025-03-19 | -5.53 |
| 2025-03-18 | -5.51 |
| 2025-03-17 | -5.64 |
| 2025-03-14 | -5.39 |
| 2025-03-13 | -5.40 |
| 2025-03-12 | -5.68 |
| 2025-03-11 | -6.10 |
| 2025-03-10 | -5.57 |
| 2025-03-07 | -5.63 |
| 2025-03-06 | -5.86 |
| 2025-03-05 | -5.65 |
| 2025-03-04 | -5.77 |
| 2025-03-03 | -5.17 |
| 2025-02-28 | -5.56 |
| 2025-02-27 | -5.36 |
| 2025-02-26 | -5.43 |
| 2025-02-25 | -5.25 |
| 2025-02-24 | -5.49 |
| 2025-02-21 | -5.62 |
| 2025-02-20 | -5.73 |
| 2025-02-19 | -5.57 |
| 2025-02-18 | -4.73 |
| 2025-02-14 | -4.67 |
| 2025-02-13 | -4.54 |
| 2025-02-12 | -4.21 |
| 2025-02-11 | -4.27 |
| 2025-02-10 | -4.88 |
| 2025-02-07 | -4.91 |